Cancer Drugs Fund driving early access to promising new treatments
NHS patients in England are getting early access to new drugs for lung cancer and sarcoma, after NICE says they should be available on the Cancer Drugs Fund (CDF).
Latest news headlines
NICE is to start assessing new digital therapies that will help treat more people with anxiety and depression.
19 June 2017
Following NICE recommendations, patients with Crohn’s disease will have routine NHS access to drug ustekinumab, which offers a new way of treating the condition.
16 June 2017
A new deal on the breast cancer drug Kadcyla (also called trastuzumab emtansine and made by Roche) means that it can now be recommended for routine funding on the NHS.
15 June 2017
NICE to work with partners on developing new ways to measure quality of life across health and social care
NICE is taking part in a project that will examine how quality of life measures used to evaluate healthcare treatments such as drugs can be extended into areas of social care and public health.
13 June 2017
NICE is launching an online tool to help medtech companies get their products to patients faster.
30 May 2017
As a public body, NICE is required to follow civil service principles on communicating during the lead up to the general election.
25 April 2017